Integrating Bioanalytical Automation, Biomarkers, Pharmacogenomics, & Cost-Effective Strategies
Conversations in Drug Development Trends
JANUARY 6, 2025
Similarly, the EMAs PRIority MEdicine (PRIME) designation and conditional marketing authorization enable accelerated approval for drugs addressing critical and underserved medical needs, provided they meet stringent evidence requirements.
Let's personalize your content